Boston Scientific Corp <BSX.N>: Bernstein cuts target price to $60 from $72
BSX•Related News
High mortgage rates to keep US housing market revival elusive
IYR•
From hallucinating AI chatbots to wiping out humanity: How did we get here?
QQQ•
NASDAQ trade halt continues <EFTY.O> reason not available at 03:58 AM
EFTY•
Global brokerages expect Fed rate hikes after strong inflation report
SPY•
Astrana Health, Inc. <ASTH.O>: Oppenheimer initiates coverage with outperform rating; target price $53
ASTH•